Gram negative pneumonia can lead to acute lung injury and perfusion abnormalities. We hypothesize that a nanocrystal suspension of G/PFC delivered IT to N and I lungs will be more homogeneously distributed at lower maximum(max) serum G levels then IV G. To test this hypothesis 22 lambs with N and acid I lungs were studied for 4 hours using 2 different drug delivery methods: N IT (n=5) and IV (n=5); I IT (n=6) and IV (n=6). Lambs were instrumented and gas ventilated. Lungs were injured with HCl acid in saline followed by liquid assisted ventilation (LAV) with perflubron (bolus FRC=20 ml/kg). G 5 mg/kg was delivered: IT (G/PFC; 20 ml/kg) and IV (aqueous injection with IT 20ml/kg PFC alone). Throughout the study serum G levels, arterial blood gases (mmHg), compliance (CDyn ml/cmH2O/kg) and mean blood pressure (MAP mmHg) were measured. Time-averaged and max serum G levels are reported. Lung G levels were measured at 4 hours and averaged across lobes. All data are expressed as means±SEM; p<0.05*. Physiologic values for the N & I lungs were: pH 7.42±0.01 & 7.39±0.01, pCO2 37±1.1 & 36±1.0, pO2 337±12 & 149±10, CDyn 0.99±0.08& 0.74±0.04, MAP 76±1.4 & 66±2.1, respectively. Distribution was more homogenous in the IT group then in the IV group.These data show that G lung levels in the N lung were higher in the IT group when compared to IV and similar in the I group.These findings were in spite of max serum levels in the IV groups 24x and 10x the level in the IT N and I groups, respectively. The results of this study demonstrate that in N and I lungs, homogeneous G lung levels can be more effectively achieved at lower serum levels when delivered IT in a G/PFC nanocrystal suspension as compared to IV administration. Table

Table 1 No caption available.
Full size table

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD